Streetbeat News

Regulatory

NIVF

NewGenIvf Group Ltd. (NASDAQ:NIVF) received a noncompliance notification from Nasdaq for failing to maintain a closing bid price of at least $1 per share for 30 consecutive business days. The company has until April 7 to regain compliance or risk delisting.

Portfolio Pulse from Dylan Berman

October 14, 2024 | 4:30 pm

GOOGL

Google plans to update its third-party policy in November to introduce new penalties for third parties that enable significant or sustained policy violations. This move aims to enhance compliance and ensure better adherence to Google's policies.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 4:06 pm

KO

The African regional bloc is investigating Coca-Cola for alleged anti-competitive practices. This could impact Coca-Cola's operations and market position in Africa.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 3:52 pm

BAYRY

Bayer AG has submitted an application to the European Medicines Agency for the approval of darolutamide, an oral androgen receptor inhibitor, for use in combination with androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancer. The application is based on positive Phase III ARANOTE trial results.

Portfolio Pulse from Vandana Singh

October 14, 2024 | 3:34 pm

OGI

VFF

Germany is emerging as a leader in the European cannabis market, with significant growth potential due to recent decriminalization. Companies like Village Farms International and Organigram Holdings are focusing on this market, leveraging EU GMP certification for international expansion. Canada faces profitability challenges due to high taxes, while Australia shows promise in non-combustible cannabis products.

Portfolio Pulse from Nicolás Jose Rodriguez

October 14, 2024 | 3:26 pm

BFRI

Biofrontera Inc. has announced the database lock for its Phase 3 study of Ameluz-Photodynamic Therapy in treating superficial basal cell carcinoma. The study's data is now ready for analysis, with interim results expected in November 2024. The final submission to the FDA is targeted for Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 2:31 pm

EIS

FXI

ISRA

China's Foreign Minister expressed willingness to resume exchanges with Israel as the situation eases, according to state media.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 2:26 pm

EIS

FXI

ISRA

China's Foreign Minister has urged for an immediate, complete, and permanent ceasefire in Gaza and the release of all hostages during phone talks with the Israeli Foreign Minister.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 2:12 pm

SPY

Federal Reserve's Neel Kashkari suggests that the neutral interest rate is likely higher now compared to pre-pandemic levels. This could impact market expectations and interest rate-sensitive assets.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 2:08 pm

FXI

China is considering issuing 6 trillion yuan in ultra-long special treasury bonds over three years to stimulate its slowing economy. The funds will help local governments manage off-the-books debts.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:46 pm